. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
.
.
.
.
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.